| 000 | 03750nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c383548 _d383548 |
||
| 001 | 383548 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102122127.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 170201s2017 sz | s |||| 0|eng d | ||
| 020 | _a9783319449111 | ||
| 024 | 7 |
_a10.1007/978-3-319-44911-1 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aBF39.9 _b2017 EB |
|
| 245 | 0 | 4 |
_aThe Sedated Society . _bThe Causes and Harms of our Psychiatric Drug Epidemic _cedited by James Davies |
| 250 | _a1st edition 2017 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2017 |
|
| 300 | _a1 recurso en línea (XVI, 318 páginas) | ||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 505 | 0 | _aChapter 1. Psychopharmacology is not Evidence-Based Medicine; Peter C. Gøtzsche -- Chapter 2. Starting Young: Children Cultured into Becoming Psycho-Pharmaceutical Consumers - The Example of Childhood Depression; Sami Timimi -- Chapter 3. Opium and the People: The Prescription Psychopharmaceutical Epidemic in Historical Context; Joanna Moncrieff -- Chapter 4. Desperate for a Fix: My Story of Pharmaceutical Misadventure; Luke Montagu -- Chapter 5. Neuroleptic (Antipsychotic) Drugs: An Epidemic of Tardive Dyskinesia and Related Brain Injuries Afflicting Tens of Millions; Peter R. Breggin -- Chapter 6. Psychiatry Under the Influence; Robert Whitaker -- Chapter 7. Political Pills: Psychopharmaceuticals and Neoliberalism as Mutually Supporting; James Davies -- Chapter 8. Psychopharmaceuticals as 'Essential Medicines': Local Negotiations of Global Access to Psychotherapeutic Medicines in India; China Mills -- Chapter 9. The Public and Private Lives of Psychopharmaceuticals in the Global South; Stefan Ecks -- Chapter 10. A Manifesto for Psychological Health and Wellbeing; Peter Kinderman. | |
| 520 | _aThis edited volume provides an answer to a rising public health concern: what drives the over prescription of psychiatric medication epidemic? Over 15% of the UK public takes a psychiatric medication on any given day, and the numbers are only set to increase. Placing this figure alongside the emerging clinical and scientific data revealing their poor outcomes and the harms these medications often cause, their commercial success cannot be explained by their therapeutic efficacy. Chapters from an interdisciplinary team of global experts in critical psychopharmacology rigorously examine how pharmaceutical sponsorship and marketing, diagnostic inflation, the manipulation and burying of negative clinical trials, lax medication regulation, and neoliberal public health policies have all been implicated in ever-rising psycho-pharmaceutical consumption. This volume will ignite a long-overdue public debate. It will be of interest to professionals in the field of mental health and researchers ranging from sociology of health, to medical anthropology and the political economy of health. | ||
| 988 | _aSpringer_Psychology_2017 | ||
| 650 | 7 |
_2embne _9174329 _aPsicología _xFilosofía |
|
| 700 | 1 |
_aDavies, James _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783319449104 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783319449128 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-44911-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b10/2022 _dz _ek _zSI |
||